evernorth glp-1 expanding presence with EnReachRx Evernorth Launches New Benefit Option

Each patients report is unique as coverage varies from plan to plan and drug to drug

Their combined efforts represent a significant number of clinical studies, at different stages and with differing co-agonists (Table 1)

McGregor G, Sandhu H, Bruce J, Sheehan B, McWilliams D, Yeung J, Jones C, Lara B, Smith J, Ji C, Fairbrother E, Ennis S, Heine P, Alleyne S, Guck J, Padfield E, Potter R, Mason J, Lall R, Seers K, Underwood M (2021) Rehabilitation exercise and psychological support After covid-19 InfectioN (REGAIN): a structured summary of a study protocol for a randomised controlled trial

Many individuals continue using supplements throughout their time on GLP-1 medications to help support hydration, protein intake, and overall nutrition consistency

A formal FDA decision will likely not come for several months.

This content cannot be viewed by non-subscribers/non-members.